United States · FDA National Drug Code directory
Adenosine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 23155-258_472f80bd-3964-40cb-bf81-67fccd96ae95
- Product NDC
- 23155-258
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Adenosine
- Labeler
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210301
- Source listing expiry
- 20261231
Source-listed ingredients
- ADENOSINE — 3 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (23155-258-31) / 20 mL in 1 VIAL · 23155-258-31
- 1 VIAL in 1 CARTON (23155-258-32) / 30 mL in 1 VIAL · 23155-258-32
- 10 VIAL in 1 CARTON (23155-258-41) / 20 mL in 1 VIAL · 23155-258-41
- 10 VIAL in 1 CARTON (23155-258-42) / 30 mL in 1 VIAL · 23155-258-42
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →